reviewNature Reviews Clinical OncologyFeb 28, 2019Closed access

Vessel co-option in cancer

EAElizabeth A. Kuczynski PVPeter Vermeulen FPFrancesco Pezzella RSRobert S. Kerbel ARAndrew R. Reynolds

AstraZeneca (United Kingdom) · University of Antwerp · +9 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

441

total citations

FWCI: 20.51
Percentile: 100%
References: 350

Citations per year

Authors

5

EA
Elizabeth A. KuczynskiCorresponding
AstraZeneca (United Kingdom)
PV
Peter Vermeulen
University of Antwerp, GZA Ziekenhuizen Campus Sint-Augustinus, Institute of Cancer Research, Breast Cancer Now, HistoGeneX (Belgium)
FP
Francesco Pezzella
University of Oxford, John Radcliffe Hospital
RS
Robert S. Kerbel
Sunnybrook Research Institute, Sunnybrook Health Science Centre, University of Toronto
AR
Andrew R. Reynolds
Breast Cancer Now, Institute of Cancer Research

Topics & keywords

Topics

Keywords

Angiogenesis
Medicine
Blood vessel
Metastasis
Cancer
Disease
Mechanism (biology)
Pathology

No related works found for this paper.